sales@reportocean.com (Bussiness Sales)
+18882123539 (Us - Toll Free)
+919997112116 (Rest Of World)
Antifungal Drug Market by Drug Type (Echinocandins, Azoles, Ployenes, Allylamines and Others) and by Dosage Form (Powders, Ointments, Drugs and Pastes) for Aspergillosis, Dermatophytosis, Candidiasis and Others Infection - Global Industry Perspective, Comprehensive Analysis and Forecast, 2015 - 2021

Antifungal Drug Market by Drug Type (Echinocandins, Azoles, Ployenes, Allylamines...

Home / Categories / Healthcare
Antifungal Drug Market by Drug Type (Echinocandins, Azoles, Ployenes, Allylamines and Others) and by Dosage Form (Powders, Ointments, Drugs and Pastes) for Aspergillosis, Dermatophytosis, Candidiasis and Others Infection - Global Industry Perspective, Comprehensive Analysis and Forecast, 2015 - 2021
Antifungal Drug Market by Drug...
Report Code
RO1/106/1011

Publish Date
16/Dec/2016

Pages
110
PRICE
$ 1800/-
This is a single user license, allowing one specific user access to the product. The product is a PDF.
$ 2350/-
This is a 1-5 user license, allowing up to five users have access to the product. The product is a PDF.
$ 2850/-
This is an enterprise license, allowing all employees within your organization access to the product. The product is a PDF..

Chapter 1. Introduction


1.1. Report Description And Scope

1.2. Research Scope

1.3. Research Methodology


1.3.1. Market Research Process

1.3.2. Market Research Methodology

Chapter 2. Executive Summary


2.1. Global Antifungal Drug Market, 2015 - 2021 (USD Billion)

2.2. Global Antifungal Drug Market: Snapshot

Chapter 3. Antifungal Drug  Market Dynamics


3.1. Introduction

3.2. Value Chain Analysis

3.3. Market Drivers


3.3.1. Global Antifungal Drug Market Drivers: Impact Analysis

3.3.2. Rapid Spread Of Fungal Infection

3.3.3. Pandemicity Of Fungal Infection

3.4. Market Restraints


3.4.1. Global Antifungal Drug Market Restraints: Impact Analysis

3.4.2. High Penetration Of Conventional Drugs

3.5. Opportunities


3.5.1. Covering Untapped Market

3.6. Porters Five Forces Analysis


3.6.1. Bargaining Power Of Suppliers

3.6.2. Bargaining Power Of Buyers

3.6.3. Threat From New Entrants

3.6.4. Threat From New Substitutes

3.6.5. Degree Of Competition

3.7. Market Attractiveness Analysis


3.7.1. Market Attractiveness Analysis, By Drug Type Segment

3.7.2. Market Attractiveness Analysis, By Therapeutic Indication Segment

3.7.3. Market Attractiveness Analysis, By Dosage Form Segment

3.7.4. Market Attractiveness Analysis, By Regional Segment

Chapter 4. Global Antifungal Drug Market  Competitive Landscape


4.1. Company Market Share, 2015 (Subject To Data Availability)

4.2. Strategic Development


4.2.1. Acquisitions  Mergers

4.2.2. New Type Launch

4.2.3. Agreements, Partnerships, Collaborations And Joint Ventures

4.2.4. Research And Development, Regional Expansion

4.3. Type Portfolio

Chapter 5. Global Antifungal Drug Market  Test Analysis


5.1. Global Antifungal Drug Market: Test Overview


5.1.1. Global Antifungal Drug Market Revenue Share, By Test , 2015 And 2021

5.2. Echinocandins


5.2.1. Global Echinocandins Testing Market, 2015  2021 (USD Billion)

5.3. Azoles


5.3.1. Global Azoles Market, 2015  2021 (USD Billion)

5.4. Ployenes


5.4.1. Global Ployenes Market, 2015  2021 (USD Billion)

5.5. Allylamines


5.5.1. Global Allylamines Market, 2015  2021 (USD Billion)

5.6. Others


5.6.1. Global Other Antifungal Drug Market, 2015  2021 (USD Billion)

Chapter 6. Global Antifungal Drug Market  Therapeutic Indication Analysis


6.1. Global Antifungal Drug Market: Therapeutic Indication Segment Overview


6.1.1. Global Antifungal Drug Market Revenue Share, By Therapeutic Indication, 2015 And 2021

6.2. Aspergillosis


6.2.1. Global Antifungal Drug Market For Aspergillosis, 2015  2021 (USD Billion)

6.3. Dermatophytosis


6.3.1. Global Antifungal Drug Market For Dermatophytosis, 2015  2021 (USD Billion)

6.4. Candidiasis


6.4.1. Global Antifungal Drug Market For Candidiasis, 2015  2021 (USD Billion)

6.5. Others


6.5.1. Global Antifungal Drug For Others Therapeutic Indication Market, 2015  2021 (USD Billion)

Chapter 7. Global Antifungal Drug Market  Dosage Form Analysis


7.1. Global Antifungal Drug Market: Dosage Form Segment Overview


7.1.1. Global Antifungal Drug Market Revenue Share, By Dosage Form, 2015 And 2021

7.2. Powders


7.2.1. Global Antifungal Drug Market For Powders, 2015  2021 (USD Billion)

7.3. Ointment


7.3.1. Global Antifungal Drug For Ointment Market, 2015  2021 (USD Billion)

7.4. Drugs


7.4.1. Global Antifungal Drug Market For Drugs, 2015  2021 (USD Billion)

7.5. Paste


7.5.1. Global Antifungal Drug For Paste Market, 2015  2021 (USD Billion)

Chapter 8. Global Antifungal Drug Market  Regional Segment Analysis


8.1. Global Antifungal Drug Market: Regional Overview


8.1.1. Global Antifungal Drug Market Revenue Share, By Region, 2015 And 2021

8.2. North America


8.2.1. North America Antifungal Drug Market Revenue, By Drug Type , 2015  2021 , (USD Billion)

8.2.2. North America Antifungal Drug Market Revenue, By Therapeutic Indication, 2015  2021 , (USD Billion)

8.2.3. North America Antifungal Drug Market Revenue, By Dosage Form , 2015  2021 , (USD Billion)

8.2.4. U.S.


8.2.4.1. U.S. Antifungal Drug Market Revenue, By Drug Type , 2015  2021 (USD Billion)

8.2.5. U.S.


8.2.5.1. U.S. Antifungal Drug Market Revenue, By Therapeutic Indication, 2015  2021 (USD Billion)

8.2.6. U.S.


8.2.6.1. U.S. Antifungal Drug Market Revenue, By Dosage Form , 2015  2021 (USD Billion)

8.3. Europe


8.3.1. Europe Antifungal Drug Market Revenue, By Drug Type , 2015  2021 (USD Billion)

8.3.2. Europe Antifungal Drug Market Revenue, By Therapeutic Indication, 2015  2021 (USD Billion)

8.3.3. Europe Antifungal Drug Market Revenue, By Dosage Form , 2015  2021 (USD Billion)

8.3.4. Germany


8.3.4.1. Germany Antifungal Drug Market Revenue, By Drug Type , 2015  2021, (USD Billion)

8.3.4.2. Germany Antifungal Drug Market Revenue, By Therapeutic Indication, 2015  2021, (USD Billion)

8.3.4.3. Germany Antifungal Drug Market Revenue, By Dosage Form , 2015  2021, (USD Billion)

8.3.5. France


8.3.5.1. France Antifungal Drug Market Revenue, By Drug Type , 2015  2021, (USD Billion)

8.3.5.2. France Antifungal Drug Market Revenue, By Therapeutic Indication, 2015  2021, (USD Billion)

8.3.5.3. France Antifungal Drug Market Revenue, By Dosage Form , 2015  2021, (USD Billion)

8.3.6. UK


8.3.6.1. UK Antifungal Drug Market Revenue, By Drug Type , 2015  2021 (USD Billion)

8.3.6.2. UK Antifungal Drug Market Revenue, By Therapeutic Indication, 2015  2021 (USD Billion)

8.3.6.3. UK Antifungal Drug Market Revenue, By Dosage Form , 2015  2021 (USD Billion)

8.4. Asia Pacific


8.4.1. Asia Pacific Antifungal Drug Market Revenue, By Drug Type , 2015  2021 (USD Billion)

8.4.2. Asia Pacific Antifungal Drug Market Revenue, By Therapeutic Indication, 2015  2021 (USD Billion)

8.4.3. Asia Pacific Antifungal Drug Market Revenue, By Dosage Form , 2015  2021 (USD Billion)

8.4.4. China


8.4.4.1. China Antifungal Drug Market Revenue, By Drug Type , 2015  2021 (USD Billion)

8.4.4.2. China Antifungal Drug Market Revenue, By Therapeutic Indication, 2015  2021 (USD Billion)

8.4.4.3. China Antifungal Drug Market Revenue, By Dosage Form , 2015  2021 (USD Billion)

8.4.5. Japan


8.4.5.1. Japan Antifungal Drug Market Revenue, By Drug Type , 2015  2021 (USD Billion)

8.4.5.2. Japan Antifungal Drug Market Revenue, By Therapeutic Indication, 2015  2021 (USD Billion)

8.4.5.3. Japan Antifungal Drug Market Revenue, By Dosage Form , 2015  2021 (USD Billion)

8.4.6. India


8.4.6.1. India Antifungal Drug Market Revenue, By Drug Type , 2015  2021 (USD Billion)

8.4.6.2. India Antifungal Drug Market Revenue, By Therapeutic Indication, 2015  2021 (USD Billion)

8.4.6.3. India Antifungal Drug Market Revenue, By Dosage Form , 2015  2021 (USD Billion)

8.5. Latin America


8.5.1. Latin America Antifungal Drug Market Revenue, By Drug Type , 2015  2021 (USD Billion)

8.5.2. Latin America Antifungal Drug Market Revenue, By Therapeutic Indication, 2015  2021 (USD Billion)

8.5.3. Latin America Antifungal Drug Market Revenue, By Dosage Form , 2015  2021 (USD Billion)

8.5.4. Brazil


8.5.4.1. Brazil Antifungal Drug Market Revenue, By Drug Type , 2015  2021 (USD Billion)

8.5.4.2. Brazil Antifungal Drug Market Revenue, By Therapeutic Indication, 2015  2021 (USD Billion)

8.5.4.3. Brazil Antifungal Drug Market Revenue, By Dosage Form , 2015  2021 (USD Billion)

8.6. Middle East And Africa


8.6.1. Middle East And Africa Antifungal Drug Market Revenue, By Drug Type , 2015  2021 (USD Billion)

8.6.2. Middle East And Africa Antifungal Drug Market Revenue, By Therapeutic Indication, 2015  2021 (USD Billion)

8.6.3. Middle East And Africa Antifungal Drug Market Revenue, By Dosage Form , 2015  2021 (USD Billion)

Chapter 9. Company Profile


9.1. Asperqillus


9.1.1. Overview

9.1.2. Financials

9.1.3. Product Portfolio

9.1.4. Business Strategy

9.1.5. Recent Developments

9.2. Alternaria


9.2.1. Overview

9.2.2. Financials

9.2.3. Product Portfolio

9.2.4. Business Strategy

9.2.5. Recent Developments

9.3. Abbott Laboratories


9.3.1. Overview

9.3.2. Financials

9.3.3. Product Portfolio

9.3.4. Business Strategy

9.3.5. Recent Developments

9.4. Pfizer


9.4.1. Overview

9.4.2. Financials

9.4.3. Product Portfolio

9.4.4. Business Strategy

9.4.5. Recent Developments

9.5. Glaxosmithkline


9.5.1. Overview

9.5.2. Financials

9.5.3. Product Portfolio

9.5.4. Business Strategy

9.5.5. Recent Developments

9.6. Bayer Healthcare


9.6.1. Overview

9.6.2. Financials

9.6.3. Product Portfolio

9.6.4. Business Strategy

9.6.5. Recent Developments

9.7. Novartis


9.7.1. Overview

9.7.2. Financials

9.7.3. Product Portfolio

9.7.4. Business Strategy

9.7.5. Recent Developments

9.8. Sanofi-Aventis


9.8.1. Overview

9.8.2. Financials

9.8.3. Product Portfolio

9.8.4. Business Strategy

9.8.5. Recent Developments

9.9. Merck  Co.


9.9.1. Overview

9.9.2. Financials

9.9.3. Product Portfolio

9.9.4. Business Strategy

9.9.5. Recent Developments

9.10. Kramer Laboratories


9.10.1. Overview

9.10.2. Financials

9.10.3. Product Portfolio

9.10.4. Business Strategy

9.10.5. Recent Developments

OUR CLIENTS

500 N Michigan Ave, Suite 600, Chicago, Illinois 60611, UNITED STATES
+18882123539
sales@reportocean.com